| Lactose (India) Ltd | 143 Cr. | 114 | 237/84.3 | 31.7 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.38 Cr. | 1.77 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,264 Cr. | 391 | 479/192 | 88.3 | 24.3 | 0.17 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.0 Cr. | 43.1 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 46.1 Cr. | 31.5 | 32.0/17.0 | 110 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 55.7 Cr. | 74.0 | 124/69.7 | 15.1 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 55,502 Cr. | 1,966 | 2,286/1,275 | 22.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 313 Cr. | 12.9 | 19.0/10.8 | 18.8 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 18.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 823 Cr. | 1,743 | 1,999/635 | 28.5 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 98.4 Cr. | 19.7 | 32.0/17.0 | 26.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,032 Cr. | 351 | 449/219 | 9.21 | 133 | 0.71 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.54 Cr. | 21.6 | 39.0/21.6 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.50 Cr. | 3.01 | 8.45/2.11 | 4.26 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 469 Cr. | 483 | 499/211 | 70.8 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,339 Cr. | 998 | 1,565/978 | 39.3 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 51.1 Cr. | 0.25 | 1.12/0.25 | 3.36 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 36.6 Cr. | 13.9 | 26.3/7.10 | 17.8 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.63 Cr. | 9.54 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 161 Cr. | 452 | 859/431 | 9.14 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 85.5 Cr. | 85.5 | 92.5/26.1 | 161 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,409 Cr. | 1,379 | 2,452/1,334 | 44.8 | 174 | 0.78 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 24.8 Cr. | 54.3 | 88.7/36.1 | 53.9 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.8 Cr. | 5.10 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.5 Cr. | 124 | 152/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 58.7 Cr. | 107 | 114/9.41 | 40.5 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 34.0 Cr. | 45.0 | 80.0/33.0 | 54.8 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.15 Cr. | 20.5 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,374 Cr. | 542 | 1,028/514 | 26.6 | 72.4 | 0.22 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 81.5 Cr. | 18.9 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.1 Cr. | 22.0 | 43.7/17.4 | 48.5 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 86,868 Cr. | 2,106 | 3,055/2,103 | 52.1 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 239 Cr. | 415 | 524/241 | 24.5 | 123 | 1.08 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 53.1 Cr. | 37.0 | 62.6/26.7 | 83.0 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 68,470 Cr. | 1,178 | 1,365/994 | 20.0 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 158 Cr. | 253 | 303/159 | 150 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 789 Cr. | 78.6 | 123/74.0 | 20.4 | 32.6 | 1.91 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 40.5 Cr. | 31.0 | 49.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,873 Cr. | 1,694 | 1,902/919 | 61.9 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.16 Cr. | 0.63 | 1.38/0.51 | 104 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 223 Cr. | 29.2 | 65.0/26.0 | 14.3 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 4.90 Cr. | 8.37 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 134 Cr. | 5.68 | 6.57/2.82 | 311 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 59,064 Cr. | 27,805 | 37,000/25,260 | 39.1 | 1,888 | 1.71 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,856 Cr. | 755 | 972/550 | 28.6 | 226 | 0.66 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 190 Cr. | 67.7 | 100/31.3 | 53.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,111 Cr. | 1,654 | 1,740/740 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,074 Cr. | 1,357 | 1,870/1,110 | 402 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 836 Cr. | 239 | 330/154 | 19.4 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,057 Cr. | 789 | 840/270 | 16.7 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,272 Cr. | 465 | 808/432 | 22.5 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,489 Cr. | 1,053 | 1,595/991 | 21.1 | 768 | 0.95 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,27,480 Cr. | 3,765 | 3,882/2,886 | 58.8 | 250 | 0.85 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 947 Cr. | 103 | 284/98.0 | | 41.3 | 0.49 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,391 Cr. | 14.8 | 23.5/14.1 | 22.2 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,590 Cr. | 538 | 1,328/521 | 59.9 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,911 Cr. | 172 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,27,358 Cr. | 1,781 | 1,910/1,547 | 37.0 | 324 | 0.90 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,601 Cr. | 586 | 744/441 | 406 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,960 Cr. | 316 | 335/175 | 36.5 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,357 Cr. | 325 | 502/265 | 41.1 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,353 Cr. | 211 | 260/111 | 124 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,604 Cr. | 4,170 | 6,718/4,146 | 26.0 | 340 | 2.81 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,837 Cr. | 2,322 | 2,725/1,772 | 34.4 | 335 | 0.86 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,420 Cr. | 5,685 | 6,739/4,904 | 30.7 | 373 | 2.20 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 171 Cr. | 48.6 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,989 Cr. | 5,021 | 5,993/3,701 | 32.5 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 124 Cr. | 100 | 224/81.0 | 12.8 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,151 Cr. | 351 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,204 Cr. | 830 | 1,998/604 | 80.4 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 20,707 Cr. | 16,123 | 19,748/10,060 | 106 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 475 Cr. | 21.2 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,506 Cr. | 921 | 1,490/660 | 10.7 | 483 | 0.65 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,240 Cr. | 40.9 | 87.7/40.0 | 29.7 | 21.8 | 0.49 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,464 Cr. | 187 | 332/162 | 24.1 | 59.3 | 0.43 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 39.7 Cr. | 25.0 | 130/23.6 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 265 Cr. | 74.5 | 167/72.2 | 130 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 95,610 Cr. | 2,091 | 2,403/1,774 | 22.1 | 430 | 0.57 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 980 Cr. | 488 | 945/464 | 12.2 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,088 Cr. | 1,001 | 1,040/501 | 79.2 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 966 Cr. | 931 | 1,235/596 | 19.7 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 149 Cr. | 69.0 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 629 Cr. | 130 | 227/123 | 35.7 | 104 | 2.30 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 588 Cr. | 337 | 500/265 | 21.3 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 16,888 Cr. | 1,062 | 1,250/802 | 34.0 | 414 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 27,957 Cr. | 1,785 | 1,952/1,303 | 38.9 | 243 | 0.87 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,323 Cr. | 198 | 302/193 | 30.2 | 38.0 | 1.26 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,276 Cr. | 1,431 | 1,758/1,168 | 36.6 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,398 Cr. | 81.8 | 127/57.5 | 20.6 | 59.7 | 0.98 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 780 Cr. | 95.4 | 124/67.2 | 26.3 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,252 Cr. | 245 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,991 Cr. | 243 | 457/217 | 296 | 96.9 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,352 Cr. | 1,587 | 2,496/1,243 | 30.8 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,563 Cr. | 352 | 498/285 | 65.6 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,938 Cr. | 574 | 621/412 | 27.3 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 55,502 Cr. | 1,966 | 2,286/1,275 | 22.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,852 Cr. | 2,586 | 3,516/1,921 | 46.0 | 101 | 1.62 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,422 Cr. | 1,664 | 2,131/1,200 | 23.7 | 610 | 1.08 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,851 Cr. | 421 | 528/359 | 30.4 | 149 | 1.19 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,208 Cr. | 1,557 | 1,910/1,097 | 51.0 | 227 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,06,591 Cr. | 1,277 | 1,406/1,020 | 18.5 | 432 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,612 Cr. | 231 | 322/178 | 24.2 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,194 Cr. | 1,500 | 1,673/1,310 | 22.3 | 408 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,790 Cr. | 1,946 | 2,641/1,551 | 25.1 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 282 Cr. | 97.1 | 203/93.5 | 20.2 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,520 Cr. | 144 | 191/105 | 13.9 | 107 | 0.35 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 56.1 Cr. | 34.4 | 67.7/32.6 | 19.7 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 51,473 Cr. | 385 | 425/291 | 108 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,622 Cr. | 1,607 | 2,050/1,430 | 35.8 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 117 Cr. | 73.5 | 132/70.0 | 17.1 | 49.2 | 1.63 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 321 Cr. | 141 | 205/67.8 | 30.4 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,535 Cr. | 9,016 | 10,691/6,301 | 97.5 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,999 Cr. | 684 | 843/544 | 35.3 | 118 | 0.67 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 165 Cr. | 78.2 | 137/75.0 | 8.74 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 67,813 Cr. | 5,664 | 5,868/4,492 | 28.8 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,651 Cr. | 847 | 1,124/725 | 26.2 | 271 | 1.30 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 425 Cr. | 745 | 1,449/736 | | 690 | 0.67 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 32,473 Cr. | 2,596 | 3,116/2,022 | 33.4 | 345 | 1.08 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,432 Cr. | 306 | 392/258 | 23.3 | 133 | 1.70 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,541 Cr. | 388 | 575/312 | 18.6 | 147 | 0.26 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,316.98 Cr | 1,151.54 | | 52.61 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |